Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siavash Moradi

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Infectious Disorders Drug Targets|February 29, 2020
Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-associated Pneumonia Caused by Multidrugresistant Bacteria: A Randomized, Single-blind Clinical TrialMahila Monajati, Shahram Ala, Masoud Aliyali, et al.
Iranian Journal of Medical Sciences|January 12, 2022
Aldolase C Profiling in Serum after Mild Traumatic Brain Injury: A Prospective Cohort StudyKaveh Haddadi, Siavash Moradi, Leila Asadian, et al.
Iranian Journal of Pharmaceutical Research : IJPR|February 23, 2022
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical TrialZahra Nekoukar, Shahram Ala, Siavash Moradi, et al.
Nursing Open|March 15, 2024
The impact of student computer competency on e-learning outcomes: A path analysis model of virtual learning infrastructure, collaboration, and access to electronic facilitiesHamid Sharif-Nia, Gökmen Arslan, Jonathan Reardon, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2020
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trialHamideh Abbaspour Kasgari, Siavash Moradi, Amir Mohammad Shabani, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Infectious Disorders Drug Targets|February 29, 2020
Clinical Effectiveness of a High Dose Versus the Standard Dose of Meropenem in Ventilator-associated Pneumonia Caused by Multidrugresistant Bacteria: A Randomized, Single-blind Clinical TrialMahila Monajati, Shahram Ala, Masoud Aliyali, et al.
Iranian Journal of Medical Sciences|January 12, 2022
Aldolase C Profiling in Serum after Mild Traumatic Brain Injury: A Prospective Cohort StudyKaveh Haddadi, Siavash Moradi, Leila Asadian, et al.
Iranian Journal of Pharmaceutical Research : IJPR|February 23, 2022
Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical TrialZahra Nekoukar, Shahram Ala, Siavash Moradi, et al.
Nursing Open|March 15, 2024
The impact of student computer competency on e-learning outcomes: A path analysis model of virtual learning infrastructure, collaboration, and access to electronic facilitiesHamid Sharif-Nia, Gökmen Arslan, Jonathan Reardon, et al.
The Journal of Antimicrobial Chemotherapy|August 20, 2020
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomized controlled trialHamideh Abbaspour Kasgari, Siavash Moradi, Amir Mohammad Shabani, et al.
Pageof 3